Cantor Fitzgerald对aTyr Pharma首次覆盖评级为增持

同花顺iNews
Jan 07, 2025

同花顺美股讯 1月6日Cantor Fitzgerald评级报告首次覆盖atyr pharma,首次评级为增持。ATYR Pharma于11月7日发布2024年三季报,公司截至2024年9月30日,营业收入23.50万美元,同比-33.43%,净利润-4905.40万美元,基本每股收益-0.69美元。aTyr Pharma, Inc.于2005年9月8日在特拉华州注册成立。该公司是一家临床阶段的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10